Materialise NV logo

Materialise NV (06MA)

Market Closed
5 Dec, 20:00
5. 15
0
0%
- Market Cap
161.75 P/E Ratio
0% Div Yield
0 Volume
0.18 Eps
5.15
Previous Close
Day Range
5.15 5.15
Year Range
3.66 9.1
Want to track 06MA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 73 days

Summary

06MA closed Friday higher at €5.15, an increase of 0% from Thursday's close, completing a monthly decrease of -6.36% or €0.35. Over the past 12 months, 06MA stock lost -24.26%.
06MA is not paying dividends to its shareholders.
The last earnings report, released on Oct 28, 2025, exceeded the consensus estimates by 0.03%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports. The next scheduled earnings report is due on Feb 19, 2026.
The stock of the company had never split.
The company's stock is traded on 7 different exchanges and in various currencies, with the primary listing on NASDAQ (NGS) (USD).

06MA Chart

Materialise: Still Treading Water, Remains Cash Flow Positive

Materialise: Still Treading Water, Remains Cash Flow Positive

Materialise's Manufacturing segment continues to face headwinds, driven by exposure to areas like prototyping, automotive, and Europe. Materialise's Medical segment continues to perform well, and the Software segment appears set to rebound in coming quarters. Despite macro challenges, Materialise remains cash flow positive and has a strong net cash position.

Seekingalpha | 1 month ago
Materialise NV: My DCF Valuation Indicates Upside Potential

Materialise NV: My DCF Valuation Indicates Upside Potential

Materialise is rated BUY with a $10 target, offering over 60% upside potential using a DCF with conservative assumptions. MTLS's Medical segment drives growth, offsetting industrial weakness; management focuses on mass personalization in healthcare and cost control. Industrial segment faces cyclical headwinds, but MTLS is shifting toward aerospace/defense and exiting less profitable operations to improve margins.

Seekingalpha | 1 month ago
Materialise: Automotive Weakness Is Undermining The Stock

Materialise: Automotive Weakness Is Undermining The Stock

Materialise's Q2 results were weak due to European automotive headwinds and macro uncertainty. Materialise's Medical segment continues to thrive, and its Software business is nearly done transitioning to a recurring revenue model. Medical segment strength justifies a higher valuation, but the Manufacturing business must stabilize before the stock can meaningfully re-rate.

Seekingalpha | 4 months ago

Materialise NV (06MA) FAQ

What is the stock price today?

The current price is €5.15.

On which exchange is it traded?

Materialise NV is listed on NASDAQ (NGS).

What is its stock symbol?

The ticker symbol is 06MA.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0%.

What is its market cap?

As of today, no market cap data is available.

When is the next earnings date?

The next earnings report will release on Feb 19, 2026.

Has Materialise NV ever had a stock split?

No, there has never been a stock split.

Materialise NV Profile

Software Industry
Information Technology Sector
Brigitte de Vet-Veithen CEO
XMUN Exchange
US57667T1007 ISIN
BE Country
488 Employees
- Last Dividend
- Last Split
25 Jun 2014 IPO Date

Overview

Materialise NV stands as a pivotal provider in the realms of additive manufacturing and medical software, coupled with 3D printing services, which spans across the Americas, Europe and Africa, and the Asia-Pacific. With its operational foundation laid down in 1990 and headquartered in Leuven, Belgium, Materialise NV has compartmentalized its expertise into three primary segments: Materialise Software, Materialise Medical, and Materialise Manufacturing. The company has fostered collaborative agreements with eminent entities like Zimmer Biomet Holdings, Inc., Encore Medical, L.P., DePuy Synthes Companies of Johnson & Johnson, and several others, demonstrating its industry significance and widespread trust. This extensive collaboration network underscores Materialise NV's influential role in advancing 3D printing applications within both industrial and medical frameworks.

Products and Services

  • Materialise Software
  • Facilitates and enhances 3D printing operations through a comprehensive suite of software programs and platforms. This segment bridges various 3D printers with numerous software applications and capturing technologies, including CAD/CAM packages and 3D scanners. Its target clientele encompasses 3D printing machine manufacturers, production companies, and contract manufacturers across industries such as automotive, aerospace, consumer goods, and hearing aids, in addition to 3D printing service bureaus. Distribution is achieved via a direct sales force, a dedicated website, and through third-party resellers.

  • Materialise Medical
  • Focuses on delivering medical software that facilitates the analysis, planning, and engineering based on medical imaging, as well as the patient-specific design and printing of surgical devices and implants. This segment's offerings are primarily directed at medical device companies, hospitals, universities, research institutes, and industrial entities. Distribution is steered through direct sales efforts, the company's website, and Picture Archiving Communication Systems (PACS), underscoring Materialise's pivotal role in innovating medical procedures and patient care.

  • Materialise Manufacturing
  • Provides 3D printing services alongside design and engineering services, catering to the rapid prototyping and additive manufacturing needs of production parts for industrial and commercial clients. This segment encapsulates Materialise NV's direct contribution to the manufacturing industry, showcasing its capabilities in turning conceptual designs into tangible, high-quality parts and products through state-of-the-art 3D printing technologies.

Contact Information

Address: Technologielaan 15
Phone: 32 1 639 66 11